Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
11/2005
11/09/2005CN1226290C Ligands of nuclear receptor
11/09/2005CN1226284C N-sulphonyl and N-sulphinyl phenylglycinamide
11/09/2005CN1226277C Phenacylamine derivatives, production thereof and pest controllers containing the derivatives
11/09/2005CN1226250C Anthracene derivatives and organic electroluminescent device made by using the same
11/08/2005US6963017 Reacting indanone compound with coupling component
11/08/2005US6963010 Hydrophobic polyamine analogs and methods for their use
11/08/2005US6962999 Using a nickel or palladium catalyzed coupling in which the catalyst has at least one phosphine or phosphite ligand
11/08/2005US6962995 Phenanthroline derivatives
11/08/2005US6962931 Oral bioavailability of a CETP inhibitor
11/08/2005US6962929 Drugs such as 4-(N,N-Dimethylamino)-1-pentafluorophenyl-sulfonamidobenzene and/or prodrugs, used as anticarcinogenic agents, microbiocides or bactericides; tubulin inhibitors
11/08/2005CA2249222C Aminopyridine derivatives
11/08/2005CA2123691C Antiviral compositions and method for their use
11/03/2005WO2005103041A2 Treatment of cns disorders using cns target modulators
11/03/2005WO2005103033A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
11/03/2005WO2005103032A2 Novel alkyne compounds having an mch-antagonistic effect, and medicaments containing said compounds
11/03/2005WO2005103031A1 Novel alkyne compounds with an mch-antagonistic action and medicaments containing said compounds
11/03/2005WO2005103030A1 1,4-di substituted benzene compounds, process for preparing the same and use thereof
11/03/2005WO2005103013A1 Therapeutic agent for nonviral hepatitis
11/03/2005WO2005103006A1 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides
11/03/2005WO2005103005A1 PROCESS FOR SELECTIVELY PRODUCING OPTICALLY ACTIVE ISOMER OF β-PYRIDYLALANINE
11/03/2005WO2005103004A1 2-pyridinylcycloalkylbenzamide derivatives and their use as fungicides
11/03/2005WO2005103003A2 Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors
11/03/2005WO2005103002A2 Novel alkyne compounds with an mch-antagonistic action and medicaments comprising said compounds
11/03/2005WO2005102991A1 Process for production of nonnatural amino acids and intermediates therefor
11/03/2005WO2005102989A1 Non-nucleoside reverse transcriptase inhibitors
11/03/2005WO2005102980A1 Novel compounds, the preparation and the use thereof for a regiospesific synthesis of perfluor(alkyl) group heterocycles
11/03/2005WO2005102388A1 Novel blt2-mediated disease, and blt2 binding agent and compound
11/03/2005WO2005102332A1 Therapeutic agent for arthrosis deformans
11/03/2005WO2005102331A1 Therapeutic agent for osteoporosis
11/03/2005WO2005102250A1 Composition comprising a monomer compound exhibiting an optical property, method making use of said composition, a monomer compound and a polymer containing said monomer compound and the use thereof
11/03/2005WO2005003103A3 2, 4, 6-tri-substituted 6-membered heterocycles and their use in the treatment of neurodegenerative diseases
11/03/2005WO2004106304A3 3 - [2- (3-amino-2-oxo-2h-pyridin-1-yl) - acetylamino] - 4- oxo-pentanoic acid derivatives and their use as caspase inhibitors
11/03/2005US20050245747 e.g. 2-[2-(5-chloro-benzo[b]thiophen-2-yl)-phenylmethanesulfinyl]-acetamide; autoimmune disorders, antidepressant; narcolepsy, Parkinson's, Alzheimer's disease; attention deficit hyperactivity disorder; sleep disorder, fatigue
11/03/2005US20050245745 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
11/03/2005US20050245607 N-bisaryl- and n-aryl-cylcloakylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides
11/03/2005US20050245592 2-Iminopyrrolidine derivatives
11/03/2005US20050245581 3-(2-Cyanophenyl)-5-(2-methoxyphenyl)-1-phenyl-1,2-dihydropyridin-2-one; antagonists of AMPA and kainate receptors; neuroprotectants; neurodegenerative diseases; Alzheinmer's disease; antiepileptic agents; antispasmodic agents; anxiolytic agents; ddrug abuse; nervous sytem disorders; antihypoxic agents
11/03/2005US20050245580 Novel substituted dihydro 3-halo-1H-pyrazole-T-carboxylates, their preparation and use
11/03/2005US20050245551 Amide derivatives
11/03/2005US20050245543 Histamine-3 receptor antagonists
11/03/2005US20050245542 Pyridazine, pyrimidine and pyrazine ethyne compounds
11/03/2005US20050245534 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
11/03/2005US20050245530 Monocyclic heterocycles as kinase inhibitors
11/03/2005US20050245529 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
11/03/2005US20050245525 Compounds useful for inhibiting CHK1
11/03/2005US20050245512 Method and composition for rejuvinating cells, tissues organs, hair and nails
11/03/2005US20050245511 Novel compounds that inhibit tryptase activity
11/03/2005US20050245503 Therapeutic heterocycles
11/03/2005DE4000535B4 1,4-Disubstituierte 2,6-Difluorbenzolverbindungen und flüssigkristallines Medium 1,4-Disubstituted 2,6-Difluorbenzolverbindungen and liquid crystalline medium
11/03/2005DE102004017935A1 Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New alkyne compounds with MCH-antagonistic activity and pharmaceutical compositions containing them
11/03/2005DE102004017934A1 Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New alkyne compounds with MCH-antagonistic activity and pharmaceutical compositions containing them
11/03/2005DE102004017930A1 Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New alkyne compounds with MCH-antagonistic activity and pharmaceutical compositions containing them
11/03/2005CA2564356A1 Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors
11/03/2005CA2563826A1 Treatment of cns disorders using cns target modulators
11/03/2005CA2563180A1 Non-nucleoside reverse transcriptase inhibitors
11/03/2005CA2562100A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
11/03/2005CA2560692A1 2-pyridinylcycloalkylbenzamide derivatives and their use as fungicides
11/03/2005CA2560373A1 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides
11/03/2005CA2559688A1 Novel alkyne compounds with an mch-antagonistic action and medicaments comprising said compounds
11/03/2005CA2559021A1 Novel alkyne compounds with an mch-antagonistic action and medicaments containing said compounds
11/03/2005CA2558755A1 Novel alkyne compounds having an mch-antagonistic effect, and medicaments containing said compounds
11/02/2005EP1591442A1 2-Pyridinycycloalkylbenzamide derivatives and their use as fungicides
11/02/2005EP1591441A1 Carboxylic acid compounds
11/02/2005EP1590341A1 2-aminopyridine substituted heterocycles as inhibitors of cellular proliferation
11/02/2005EP1590340A1 Inhibitors of histone deacetylase
11/02/2005EP1590338A2 Modulators of melanocortin receptor
11/02/2005EP1590322A1 Carbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof
11/02/2005EP1590321A2 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/02/2005EP1590319A1 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
11/02/2005EP1436263A4 A process for preparing beta-ketoester compound
11/02/2005EP1377569B1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
11/02/2005EP1339726B1 Catalyst composition and method of polymerization
11/02/2005EP1159261B1 Antizyme modulators and their use
11/02/2005EP1005493B1 Antiviral protease inhibitors
11/02/2005CN1692109A Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
11/02/2005CN1692098A Sulfonamide derivatives, insecticides for agricultural and horticultural use, and usage thereof
11/02/2005CN1225460C Preparation of 3-cyanopyridine
11/02/2005CN1225459C NItroxyderivatives having antiinflammatory, analgesic and antithrombotic activity
11/01/2005US6960688 Use of compounds for the elevation of pyruvate dehydrogenase activity
11/01/2005US6960663 Phenyl pyridine-iridium metal complex compounds for organic electroluminescent device, process for preparing the compounds, and organic electroluminescent device using the compounds
11/01/2005US6960612 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
11/01/2005US6960599 Dopamine D2 receptor and 5-HT1A antagonists; schizophrenia; cognitive activators; Alzheimer's disease; brain disorders; strokes; antiischemic agents; anxiolytic agents; obsessive compulsive disorder; eating, sleeping and sexual disorders
11/01/2005US6960355 Modified amino acid compounds useful in delivery of active agents
10/2005
10/27/2005WO2005100484A1 Dye and dye-sensitized solar cell
10/27/2005WO2005100381A2 Processes for preparing eptifibatide and pertinent intermediate compounds
10/27/2005WO2005100353A1 Condensed pyridine derivatives useful as a28 adenosine receptor antagonists
10/27/2005WO2005100349A2 Polycyclic pyridines as potassium ion channel modulators
10/27/2005WO2005100334A1 Dipeptidyl peptidase-iv inhibitors
10/27/2005WO2005100323A1 Process for preparing pyridazinone compounds
10/27/2005WO2005100319A1 Use of pyridindione derivatives for protecting organic material against detrimental effects of light
10/27/2005WO2005100318A1 Alkanoic acids and their esters as antidiabetic agents
10/27/2005WO2005100308A1 Thio-substituted biaryl-methanesulfinyl derivatives
10/27/2005WO2005100305A1 Androgen modulators
10/27/2005WO2005100303A1 Indene derivatives and process for the preparation thereof
10/27/2005WO2005100298A1 Cetp inhibitors
10/27/2005WO2005099688A2 Cyclic compounds
10/27/2005WO2005061433A3 Aminoalcohol derivatives
10/27/2005US20050240060 Low loss high refractive index vinyl sulfide compounds and method of making same
10/27/2005US20050240024 Vapor phase catalytic chlorination of ß-picoline
10/27/2005US20050240023 Cathepsin cysteine protease inhibitors
1 ... 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 ... 633